Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites

International Journal for Parasitology

Volumn 39, Issue 12, 2009, Pages 1373-1384

  Debache, Karim ^a   Alaeddine, Ferial ^a   Guionaud, Christophe ^a   Monney, Thierry ^a   Müller, Joachim ^a   Strohbusch, Maria ^a   Leib, Stephen L ^a   Grandgirard, Denis ^a   Hemphill, Andrew ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cerebral infection; Fetal death; Micronemes; Neospora caninum; Rhoptries; Vaccine

Indexed keywords

DNA; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; PARASITE ANTIGEN; RECOMBINANT MICRONEME 1 ANTIGEN; RECOMBINANT MICRONEME 2 ANTIGEN; RHOPTRY ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN; CAUSE OF DEATH; IMMUNE RESPONSE; INFECTIOUS DISEASE; MORBIDITY; MORTALITY; PARASITE; PREGNANCY; RODENT; SURVIVAL; VACCINATION; VACCINE; VERTICAL TRANSMISSION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DISEASE MODEL; DNA DETERMINATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION PREVENTION; MORBIDITY; MORTALITY; MOUSE; NEOSPORA CANINUM; NEOSPOROSIS; NONHUMAN; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TACHYZOITE; TH2 CELL; TREATMENT OUTCOME; VERTICAL TRANSMISSION;

ANIMALS; BRAIN; BRAIN DISEASES; CERCOPITHECUS AETHIOPS; CHI-SQUARE DISTRIBUTION; DNA, COMPLEMENTARY; FEMALE; FETAL DEATH; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MICE; MICE, INBRED BALB C; NEOSPORA; POLYMERASE CHAIN REACTION; PREGNANCY; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC; VERO CELLS;

MUS; NEOSPORA CANINUM;

EID: 68049137627     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2009.04.006     Document Type: Article

References (69)

1. Alaeddine F., Keller N., Leepin A., and Hemphill A. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. J. Parasitol. 91 (2005) 657-665
2. Anderson M.L., Reynolds J.P., Rowe J.D., Sverlow K.W., Packham A.E., Barr B.C., and Conrad P.A. Evidence of vertical transmission of Neospora sp infection in dairy cattle. J. Am Vet. Med. Assoc. 210 (1997) 1169-1172
3. Baszler T.V., Long M.T., McElwain T.F., and Mathison B.A. Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice. Int. J. Parasitol. 29 (1999) 1635-1646
4. Baszler T.V., McElwain T.F., and Mathison B.A. Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease. Clin. Diagn. Lab. Immunol. 7 (2000) 893-898
5. Bjerkas I., Mohn S.F., and Presthus J. Unidentified cyst-forming sporozoon causing encephalomyelitis and myositis in dogs. Z. Parasitenkd. 70 (1984) 271-274
6. Bjorkman C., Johansson O., Stenlund S., Holmdahl O.J., and Uggla A. Neospora species infection in a herd of dairy cattle. J. Am. Vet. Med. Assoc. 208 (1996) 1441-1444
7. Bigalke R.D., Schoeman J.H., and McCully R.M. Immunization against bovine besnoitiosis with a live vaccine prepared from a blue wildebeest strain of Besnoitia besnoiti grown in cell cultures. 1. Studies on rabbits. Onderstepoort J. Vet. Res. 41 (1974) 1-5
8. Buxton D., and Innes E.A. A commercial vaccine for ovine toxoplasmosis. Parasitology 110 Suppl. (1995) S11-S16
9. Cannas A., Naguleswaran A., Müller N., Gottstein B., Eperon S., and Hemphill A. Vaccination of mice against experimental N. caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA-vaccines. Parasitology 126 (2003) 303-312
10. Cannas A., Naguleswaran A., Muller N., Gottstein B., and Hemphill A. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J. Parasitol. 89 (2003) 44-50
11. Cho J., Chung W., Song K., Na B., Kang S., Song C., and Kim T. Protective efficacy of vaccination with Neospora caninum multiple recombinant antigens against experimental Neospora caninum infection. Korean J. Parasitol. 1 (2005) 19-25
12. Davison H.C., Otter A., and Trees A.J. Estimation of vertical and horizontal transmission parameters of Neospora caninum infections in dairy cattle. Int. J. Parasitol. 29 (1999) 1683-1689
13. Debache K., Guionaud C., Alaeddine F., Mevissen M., and Hemphill A. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. Int. J. Parasitol. 38 (2008) 1455-1463
14. Dubey J.P., and Lindsay D.S. A review of Neospora caninum and neosporosis. Vet. Parasitol. 67 (1996) 1-59
15. Dubey J.P., Hattel A.L., Lindsay D.S., and Topper M.J. Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J. Am. Vet. Med. Assoc. 193 (1988) 1259-1263
16. Dubey J.P., Schares G., and Ortega-Mora L.M. Epidemiology and control of neosporosis and Neospora caninum. Clin. Microbiol. Rev. 20 (2007) 323-367
17. Dubremetz J.F., Garcia-Reguet N., Conseil V., and Fourmaux M.N. Apical organelles and host-cell invasion by apicomplexa. Int. J. Parasitol. 28 (1998) 1007-1013
18. Dubremetz J.F. Rhoptries are major players in Toxoplasma gondii invasion and host cell interaction. Cell. Microbiol. 9 (2007) 841-848
19. Ellis J., Miller C., Quinn H., Ryce C., and Reichel M.P. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model). Vaccine 26 (2008) 5989-5996
20. Eperon S., Brönnimann K., Hemphill A., and Gottstein B. Susceptibility of B-cell deficient C57BL/6 (microMT) mice to Neospora caninum infection. Parasite Immunol. 21 (1999) 225-236
21. Gondim L.F., McAllister M.M., Pitt W.C., and Zemlicka D.E. Coyotes (Canis latrans) are definitive hosts of Neospora caninum. Int. J. Parasitol. 34 (2004) 159-161
22. Gondim L.F., McAllister M.M., and Gao L. Effects of host maturity and prior exposure history on the production of Neospora caninum oocysts by dogs. Vet. Parasitol. 134 (2005) 33-39
23. Haldorson G.J., Mathison B.A., Wenberg K., Conrad P.A., Dubey J.P., Trees A.J., Yamane I., and Baszler T.V. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice. Int. J. Parasitol. 35 (2005) 1407-1415
24. Hasler B., Regula G., Stärk K.D., Sager H., Gottstein B., and Reist M. Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland. Prev. Vet. Med. 77 (2006) 230-253
25. Hasler B., Stärk K.D., Sager H., Gottstein B., and Reist M. Simulating the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle. Prev. Vet. Med. 77 (2006) 254-283
26. Hemphill A., Gottstein B., and Kaufmann H. Adhesion and invasion of bovine endothelial cells by Neospora caninum. Parasitology 112 (1996) 183-197
27. Hemphill A. The host-parasite relationship in neosporosis. Adv. Parasitol. 43 (1999) 47-104
28. Hemphill A., and Gottstein B. A European perspective on Neospora caninum. Int. J. Parasitol. 30 (2000) 877-924
29. Hemphill A., Vonlaufen N., and Naguleswaran A. Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum. Parasitology 133 (2006) 261-278
30. Hemphill A., Mueller J., and Esposito M. Nitazoxamide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin. Pharmacother. 7 (2006) 953-964
31. Hemphill A. Response to Innes and Mattsson: Neospora caninum emerges from the shadow of Toxoplasma gondii. Trends Parasitol. 23 (2007) 44-45
32. Hernandez J., Risco C., and Donovan A. Risk of abortion associated with Neospora caninum during different lactations and evidence of congenital transmission in dairy cows. J. Am. Vet. Med. Assoc. 221 (2002) 1742-1746
33. Innes E.A., Andrianarivo A.G., Bjorkman C., Williams D.J., and Conrad P.A. Immune responses to Neospora caninum and prospects for vaccination. Trends Parasitol. 18 (2002) 497-504
34. Innes E.A. The host-parasite relationship in pregnant cattle infected with Neospora caninum. Parasitology 134 (2007) 1903-1910
35. Innes E.A., and Mattsson J.G. Neospora caninum emerges from the shadow of Toxoplasma gondii. Trends Parasitol. 23 (2007) 43-44
36. Jenkins M., Parker C., Tuo W., Vinyard B., and Dubey J.P. Inclusion of CpG adjuvant with plasmid Dann coding for NcGRA7 improves protection against congenital neosporosis. Infect. Immun. 72 (2004) 1817-1819
37. Khan I.A., Schwartzman J.D., Matsuura T., and Kasper L.H. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc. Natl. Acad. Sci. USA 94 (1997) 13955-13960
38. Keller N., Naguleswaran A., Cannas A., Vonlaufen N., Bienz M., Björkman C., Bohne W., and Hemphill A. Identification of a Neospora caninum microneme protein (NcMIC1) which interacts with sulfated host cell surface glycosaminoglycans. Infect. Immun. 70 (2002) 3187-3198
39. Lindsay D.S., and Dubey J.P. Confirmation that the dog is the definitive host for Neospora caninum. Vet. Parasitol. 82 (1999) 327-333
40. Liddell S., Jenkins M.C., Collica C.M., and Dubey J.P. Prevention of vertical transfer of Neospora caninum in BALB/c mice by vaccination. J. Parasitol. 85 (1999) 1072-1075
41. Liddell S., Parker C., Vinyard B., Jenkins M., and Dubey J.P. Immunization of mice with plasmid DNA coding for NcGRA7 and NcHSP33 confers partial protection against vertical transmission of Neospora caninum. J. Parasitol. 89 (2003) 496-500
42. Long M.T., Baszler T.V., and Mathison B.A. Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum. J. Parasitol. 84 (1998) 316-320
43. Lòpez-Pérez I.C., Risco-Castillo V., Collantes-Fernandez E., and Ortega-Mora L.M. Comparative effects of Neospora caninum infection in BALB/c mice at three different gestation periods. J. Parasitol. 92 (2006) 1286-1291
44. Lòpez-Pérez I.C., Collantes-Fernòndez E., Aguado-Martìnez A., Rodrìguez-Bertos A., and Ortega-Mora L.M. Influence of Neospora caninum infection in BALB/c mice during pregnancy in post-natal development. Vet. Parasitol. 155 (2008) 175-183
45. Martin A.M., Liu T., Lynn B.C., and Sinai A.P. The Toxoplasma gondii parasitophorous vacuole membrane: transactions across the border. J. Eukaryot. Microbiol. 54 (2007) 25-28
46. McAllister M.M., Dubey J.P., Lindsay D.S., Jolley W.R., Wills R.A., and McGuire A.M. Dogs are definitive hosts of Neospora caninum. Int. J. Parasitol. 28 (1998) 1473-1478
47. Müller N., Vonlaufen N., Gianinazzi C., Leib S.L., and Hemphill A. Application of real time fluorescent PCR for quantitative assessment of Neospora caninum infections in organotypic slice cultures of rat central nervous tissue. J. Clin. Microbiol. 40 (2002) 252-255
48. Naguleswaran A., Cannas A., Keller N., Vonlaufen N., Schares G., Conraths F.J., Björkman C., and Hemphill A. Neospora caninum microneme protein NcMIC3: secretion, subcellular localization, and functional involvement in host cell interaction. Infect. Immun. 69 (2001) 6483-6494
49. Naguleswaran A., Cannas A., Keller N., Vonlaufen N., Björkman C., and Hemphill A. Vero cell surface proteoglycan interaction with the microneme protein NcMIC3 mediates adhesion of Neospora caninum tachyzoites to host cells unlike that in Toxoplasma gondii. Int. J. Parasitol. 32 (2002) 695-704
50. Nishikawa Y., Xuan X., Nagasawa H., Igarashi I., Fujisaki K., Otsuka H., and Mikami T. Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine 19 (2001) 1710-1716
51. Nishikawa Y., Kousaka Y., Tragoolpua K., Xuan X., Makala L., Fujisaki K., Mikami T., and Nagasawa H. Characterization of Neospora caninum surface protein NcSRS2 based on baculovirus expression system and its application for serodiagnosis of Neospora infection. J. Clin. Microbiol. 39 (2001) 3987-3991
52. Nishikawa Y., Inoue N., Makala L., and Nagasawa H. A role for balance of interferon-gamma and interleukin-4 production in protective immunity against Neospora caninum infection. Vet. Parasitol. 116 (2003) 175-184
53. Peters M., Lütkefels E., Heckeroth A.R., and Schares G. Immunohistochemical and ultrastructural evidence for Neospora caninum tissue cysts in skeletal muscles of naturally infected dogs and cattle. Int. J. Parasitol. 31 (2001) 1144-1148
54. Pfeiffer D.U., Williamson N.B., Reichel M.P., Wichtel J.J., and Teague W.R. A longitudinal study of Neospora caninum infection on a dairy farm in New Zealand. Prev. Vet. Med. 54 (2002) 11-24
55. Pinitkiatisakul S., Mattsson J.G., Wikman M., Friedman M., Bengtsson K.L., Ståhl S., and Lundén A. Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms. Vet. Parasitol. 129 (2005) 25-34
56. Pinitkiatisakul S., Friedman M., Wikman M., Mattsson J.G., Lövgren-Bengtsson K., Ståhl S., and Lundén A. Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations. Vaccine 25 (2007) 3658-3668
57. Ramamoorthy S., Sanakkayala N., Vemulapalli R., Jain N., Lindsay D.S., Schurig G.S., Boyle S.M., and Sriranganathan N. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. Caninum protective antigens. Int. J. Parasitol. 37 (2007) 1531-1538
58. Ramamoorthy S., Sanakkayala N., Vemulapalli R., Duncan R.B., Lindsay D.S., Schurig G.S., Boyle S.M., Kasimanickam R., and Sriranganathan N. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens. Int. J. Parasitol. 37 (2007) 1521-1529
59. Reichel M.P. Neospora caninum infections in Australia and New Zealand. Aust. Vet. J. 78 (2000) 258-261
60. Saeij J.P.J., Coller S., Boyle J.P., Jerome M.E., White M.W., and Boothroyd J.C. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445 (2007) 324-327
61. Shirley M.W., and Bedrník P. Live attenuated vaccines against avian coccidiosis: success with precocious and egg-adapted lines of Eimeria. Parasitol. Today 13 (1997) 481-484
62. Sonda S., Fuchs N., Gottstein B., and Hemphill A. Molecular characterization of a novel microneme antigen in Neospora caninum. Mol. Biochem. Parasitol. 108 (2000) 39-51
63. Srinivasan S., Müller J., Suana A., and Hemphill A. Vaccination with micronem protein NcMIC4 increases mortality in mice inoculated with Neospora caninum. J. Parasitol. 92 (2007) 1235-1243
64. Strohbusch M., Müller N., Hemphill A., Greif G., and Gottstein B. NcGRA2 as a molecular target to assess the parasiticidal activity of toltrazuril against Neospora caninum. Parasitology 135 (2008) 1065-1073
65. Strohbusch M., Müller N., Hemphill A., Greif G., and Gottstein B. NcGRA2-RT-PCR to detect live versus dead parasites in Neospora caninum infected mice. Open Parasitol. J. 2 (2008) 64-68
66. Thurmond M.C., and Hietala S.K. Culling associated with Neospora caninum infection in dairy cows. Am. J. Vet. Res. 57 (1996) 1559-1562
67. Wessel D., and Flügge U.I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138 (1984) 141-143
68. Williams D.J.L., and Trees A.J. Protecting babies: vaccine strategies to prevent foetal infection in Neospora caninum infected cattle. Parasite Immunol. 28 (2006) 61-67
69. Williams D.J., Guy C.S., Smith R.F., Ellis J., Björkman C., Reichel M.P., and Trees A.J. Immunization of cattle with live tachyzoites of Neospora caninum confers protection against fetal death. Infect. Immun. 75 (2007) 1343-1348